We plotted the effect sizes of 48 variants compiled from two sources (Catalogue of Somatic Mutations in Cancer [COSMIC]31,45 and Muppidi et al.25)and observed that nearly all of these variants reduced P2RY8 expression and decreased its migration inhibition, and none of them showed increased expression or function (Figure 7C). Here, P2RY8 is linked to cancer.